FDA Inspection
Rubicon Research Private LimitedFDA Inspection 828916 - Rubicon Research Private Limited - April 11, 2013
Record Details
This FDA Inspection record concerns Rubicon Research Private Limited, with an inspection on April 11, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 11, 2013
- Product Type
- Drugs
View Company Profile
ID · 740ab444-c2c2-4f90-aa83-47590106fff5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 828916
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Rubicon Research Private Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2024 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| March 8, 2024 | NAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| January 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rubicon Research Private Limited
- FDA Inspection 1250746 - 2024-11-07
- FDA Inspection 1231826 - 2024-03-08
- FDA Inspection 1195651 - 2023-01-27
- FDA Inspection 1038536 - 2017-11-20
- FDA Inspection 924394 - 2015-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.